Posts

Monday Miscellany

Commercial success is a nothing-burger for the EPO in Wegovy patent inventive step analysis (T 1701/22, Obesity treatment with semaglutide)

Never Too Late: If you missed the IPKat last week!

The benefits and pitfalls of drug manufacturing IP (T 2543/22)

The patent debate surrounding PrEP, the game-changer in HIV prevention